Does initial therapy with a GLP-1 agonist in adults diagnosed with type 2 diabetes mellitus lead to better outcomes than traditional initial therapy with metformin?

Abstract

University of Oklahoma College of Medicine Tulsa, The University of Oklahoma School of Community Medicine, Tulsa, OK The corresponding author is Starr Harmon, DO; [email protected]. The authors declare no conflicts of interest.